Barinthus Biotherapeutics Plc Stock Market Value
| BRNS Stock | 0.89 0.10 10.10% |
| Symbol | Barinthus |
Barinthus Biotherapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Barinthus Biotherapeutics. If investors know Barinthus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Barinthus Biotherapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.49) | Revenue Per Share 0.384 | Quarterly Revenue Growth (1.00) | Return On Assets (0.19) | Return On Equity (0.33) |
The market value of Barinthus Biotherapeutics is measured differently than its book value, which is the value of Barinthus that is recorded on the company's balance sheet. Investors also form their own opinion of Barinthus Biotherapeutics' value that differs from its market value or its book value, called intrinsic value, which is Barinthus Biotherapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Barinthus Biotherapeutics' market value can be influenced by many factors that don't directly affect Barinthus Biotherapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Barinthus Biotherapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Barinthus Biotherapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Barinthus Biotherapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Barinthus Biotherapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Barinthus Biotherapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Barinthus Biotherapeutics.
| 10/26/2024 |
| 11/25/2024 |
If you would invest 0.00 in Barinthus Biotherapeutics on October 26, 2024 and sell it all today you would earn a total of 0.00 from holding Barinthus Biotherapeutics plc or generate 0.0% return on investment in Barinthus Biotherapeutics over 30 days. Barinthus Biotherapeutics is related to or competes with Global Ship, Tyson Foods, China Aircraft, Bridgford Foods, FTAI Aviation, and Albertsons Companies. Barinthus Biotherapeutics is entity of United States More
Barinthus Biotherapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Barinthus Biotherapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Barinthus Biotherapeutics plc upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.08) | |||
| Maximum Drawdown | 40.24 | |||
| Value At Risk | (8.16) | |||
| Potential Upside | 8.13 |
Barinthus Biotherapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Barinthus Biotherapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Barinthus Biotherapeutics' standard deviation. In reality, there are many statistical measures that can use Barinthus Biotherapeutics historical prices to predict the future Barinthus Biotherapeutics' volatility.| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.45) | |||
| Total Risk Alpha | (1.25) | |||
| Treynor Ratio | (0.40) |
Barinthus Biotherapeutics Backtested Returns
Barinthus Biotherapeutics secures Sharpe Ratio (or Efficiency) of -0.0604, which signifies that the company had a -0.0604% return per unit of risk over the last 3 months. Barinthus Biotherapeutics plc exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Barinthus Biotherapeutics' Standard Deviation of 5.74, mean deviation of 3.53, and Risk Adjusted Performance of (0.04) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.85, which signifies possible diversification benefits within a given portfolio. Barinthus Biotherapeutics returns are very sensitive to returns on the market. As the market goes up or down, Barinthus Biotherapeutics is expected to follow. At this point, Barinthus Biotherapeutics has a negative expected return of -0.35%. Please make sure to confirm Barinthus Biotherapeutics' skewness, as well as the relationship between the day median price and relative strength index , to decide if Barinthus Biotherapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.36 |
Below average predictability
Barinthus Biotherapeutics plc has below average predictability. Overlapping area represents the amount of predictability between Barinthus Biotherapeutics time series from 26th of October 2024 to 10th of November 2024 and 10th of November 2024 to 25th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Barinthus Biotherapeutics price movement. The serial correlation of 0.36 indicates that just about 36.0% of current Barinthus Biotherapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.36 | |
| Spearman Rank Test | -0.24 | |
| Residual Average | 0.0 | |
| Price Variance | 0.05 |
Barinthus Biotherapeutics lagged returns against current returns
Autocorrelation, which is Barinthus Biotherapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Barinthus Biotherapeutics' stock expected returns. We can calculate the autocorrelation of Barinthus Biotherapeutics returns to help us make a trade decision. For example, suppose you find that Barinthus Biotherapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Barinthus Biotherapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Barinthus Biotherapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Barinthus Biotherapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Barinthus Biotherapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Barinthus Biotherapeutics Lagged Returns
When evaluating Barinthus Biotherapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Barinthus Biotherapeutics stock have on its future price. Barinthus Biotherapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Barinthus Biotherapeutics autocorrelation shows the relationship between Barinthus Biotherapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Barinthus Biotherapeutics plc.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Barinthus Stock Analysis
When running Barinthus Biotherapeutics' price analysis, check to measure Barinthus Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Barinthus Biotherapeutics is operating at the current time. Most of Barinthus Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Barinthus Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Barinthus Biotherapeutics' price. Additionally, you may evaluate how the addition of Barinthus Biotherapeutics to your portfolios can decrease your overall portfolio volatility.